Two major approaches for BC cure are the developmentof tyrosine kinase inhibitors and targeting the ligand-binding domains of HER2 by monoclonal antibodies that prevent the dimerization and subsequently the intracellular signaling cascade [10]. The gene discussed is ERBB2; the disease is breast cancer.